ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
36.63B
Market cap36.63B
Price-Earnings ratio
25.40
Price-Earnings ratio25.40
Dividend yield
0.91%
Dividend yield0.91%
Average volume
649.98K
Average volume649.98K
High today
$251.54
High today$251.54
Low today
$246.96
Low today$246.96
Open price
$247.00
Open price$247.00
Volume
204.26K
Volume204.26K
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

With a market cap of 36.63B, ResMed(RMD) trades at $250.92. The stock has a price-to-earnings ratio of 25.40 and currently yields dividends of 91.1%.

On 2026-01-08, ResMed(RMD) stock moved within a range of $246.96 to $251.54. With shares now at $250.92, the stock is trading +1.6% above its intraday low and -0.2% below the session's peak.

Trading volume for ResMed(RMD) stock has reached 204.26K, versus its average volume of 649.98K.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

RMD News

TipRanks 17h
ResMed Director Peter Farrell Plans Additional Insider Share Sale Under Rule 144

Claim 70% Off TipRanks Premium The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ). ResMed...

TipRanks 17h
ResMed General Counsel Discloses Small Share Sale Under 10b5-1 Trading Plan

Claim 70% Off TipRanks Premium An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available. ResMed Inc...

Simply Wall St 1d
How Earnings Beat Expectations And Growth Outlook At ResMed Has Changed Its Investment Story

ResMed recently entered its fiscal second-quarter 2026 earnings season with analysts expecting diluted earnings of US$2.68 per share, implying low double-digit...

How Earnings Beat Expectations And Growth Outlook At ResMed Has Changed Its Investment Story

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
24.1%
Sell
3.4%

More RMD News

TipRanks 3d
ResMed Updates CDI and Share Structure for December 2025

Claim 70% Off TipRanks This Holiday Season Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update. ResMed...

Simply Wall St 3d
ResMed Valuation Check As Investors Await Fiscal Q2 Earnings Update

ResMed (RMD) is back in focus as the company approaches its fiscal second quarter 2026 earnings release, with analysts watching closely after several quarters o...

ResMed Valuation Check As Investors Await Fiscal Q2 Earnings Update
Simply Wall St 6d
ResMed Inc. is favoured by institutional owners who hold 69% of the company

Key Insights Significantly high institutional ownership implies ResMed's stock price is sensitive to their trading actions A total of 25 investors have a majo...

ResMed Inc. is favoured by institutional owners who hold 69% of the company

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.